DiabetologyNews.net

Diabetology Xagena

Search results for "Onglyza"

Phase III data demonstrated that Saxagliptin ( Onglyza ), an inhibitor of dipeptidyl-peptidase-4 ( DPP-4 ), in combination with Metformin, exhibited a statistically significant improvement in glycemic ...


Results from an investigational phase 3b clinical study have shown that Onglyza ( Saxagliptin ) 5 mg added to Insulin ( with or without Metformin ) significantly reduced glycosylated hemoglobin levels ...


The EMA ( European Medicines Agency ) is investigating findings by a group of independent academic researchers that suggest an increased risk of pancreatitis ( inflammation of the pancreas ) and preca ...


The cardiovascular safety and efficacy of many current antihyperglycemic agents, including Saxagliptin ( Onglyza ), a dipeptidyl peptidase 4 ( DPP-4 ) inhibitor, are unclear.Researchers have randomly ...


The FDA ( Food and Drug Administration ) has found that type 2 diabetes medicines containing Saxagliptin and Alogliptin may increase the risk of heart failure, particularly in patients who already hav ...